Research Insight
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Research Insight sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Research Insight: 15 sponsored US clinical trials, 1 recruiting.
Research Insight sponsors 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 7 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dry Eye, with 2 trials.
Top-decile sponsor footprint
Research Insight ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
15 total, page 1 of 1
The THINK Study Incidence of Neurotrophic Keratopathy)
NCT06482164
The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
NCT07276802
2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
NCT07144644
The COAT Trial: Cequa's Onset of Action Trial
NCT06482177
The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction
NCT05346172
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148
Evaluation of the Accuracy & Safety of the LaserArcs Nomogram
NCT05278442
The DEPOT Study (Dry Eye Prescription Options for Therapy)
NCT04911361
The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study
NCT04669561
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
NCT04495049
Veracity Surgical: A Time/Motion and Quality of Care Study
NCT04337892
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
NCT04342988
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
NCT04273282
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
NCT04146961
Comparison of Pre-operative Measurements With Intraoperative Aberrometry in Predicting Correction for Low Toric Lens Correction in Cataract Surgery
NCT04247152
Where Research Insight enrollment is open (later-stage tilt)
1 recruiting of 15 indexed (7% open); 13 completed (87%).
Phase mix: 7 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Dry Eye (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Research Insight: open-pipeline peers nationwide
Peers matched on 15 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Research Insight sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 trials (± recruiting share)
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Baylor Breast Care Center · 7% recruiting · 15 trials
- Geron Corporation · 7% recruiting · 15 trials
- Guerbet · 7% recruiting · 15 trials
- Joanne Kurtzberg, MD · 7% recruiting · 15 trials
Related
What to do with this Research Insight page
15 registered trials is a research-attention snapshot, not an endorsement of Research Insight or any single study.
- 1 of Research Insight's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Dry Eye is the condition Research Insight studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Eye trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Research Insight pipeline card: 15 registered trials from official public datasets.Report a data error.